The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Stock and Other Ownership Interests - JSK Therapeutics; Lone Star Thiotherapies
Consulting or Advisory Role - Baxalta; Tolero Pharmaceuticals
Research Funding - Amgen; Cantex Pharmaceuticals
Patents, Royalties, Other Intellectual Property - JSK Therapeutics
 
Consulting or Advisory Role - Caremore; Pfizer
Research Funding - Abbvie; Amgen; GlycoMimetics; JW Pharmaceutical
Dose escalation results of a phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in patients (Pts) with relapsed/refractory (r/r) acute myeloid leukemia (AML).
 
Harry Paul Erba
Consulting or Advisory Role - Amgen; Celator/Jazz; Celgene; Daiichi Sankyo; ImmunoGen; Incyte; Millennium; Novartis; Ono Pharmaceutical; Pfizer; Seagen; Sunesis Pharmaceuticals; Takeda
Speakers' Bureau - Celgene; Incyte; Novartis
Research Funding - Agios; Amgen; Astellas Pharma; Celator; Daiichi Sankyo; ImmunoGen; Janssen; Juno Therapeutics; Millennium; Seagen
Other Relationship - Celgene; GlycoMimetics
 
Pamela S. Becker
No Relationships to Disclose
 
Paul J. Shami
No Relationships to Disclose
 
Michael Richard Grunwald
Stock and Other Ownership Interests - Medtronic
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; ARIAD; Incyte; Pfizer
Research Funding - Amgen; FORMA Therapeutics; Incyte; Janssen
 
Donna L. Flesher
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Yilong Zhang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Erik Rasmussen
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Travel, Accommodations, Expenses - Amgen
 
Haby A. Henary
No Relationships to Disclose
 
Eunice S. Wang
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Seagen; Sigma-Tau; Spectrum Pharmaceuticals
Speakers' Bureau - Incyte
Research Funding - Immunogen (Inst)